Patient compliance was a serious concern, particularly regarding the reduction of sun exposure. Running a dermatology trial, especially in the middle of summer, can greatly affect patient compliance and the resulting, potential flare-ups in any dermatological condition.
Biorasi implemented various layers of risk mitigation to assist in offsetting any foreseen compliance issues. To counteract patient non-compliance during summer months, summer enrollment was planned to incorporate a higher percentage of northern states where temperature severity is not as commonly noted.
Read more to learn the details on how risk mitigation along with a two-fold feasibility process allowed the study to surpass initial enrollment projections.